The inhibition of 3H-glutamine uptake by perturbing SLC1A5 and/or SLC38A2 expression genetically, or by inhibiting their activity with GPNA independently of siRNA, though significant, did reveal residual uptake activity in HCC cells (Figure 6B,E,H,J). The gene discussed is SLC38A2; the disease is hepatocellular carcinoma.